The Department of Health and Human Services, through the U.S. Food and Drug Administration (FDA), is offering a funding opportunity aimed at enhancing antibiotic resistance surveillance within the National Antimicrobial Resistance Monitoring System (NARMS). This initiative focuses on collecting and analyzing retail food samples to strengthen public health measures against antibiotic-resistant bacteria. The funding, totaling up to $5 million for fiscal year 2025, is designated for cooperative agreements that will support enhanced detection and sampling strategies for various enteric bacteria in retail food commodities. The application process involves key dates for submission, including letters of intent and application due dates spanning from July 2025 to April 2027. Eligible applicants include a broad range of organizations such as higher education institutions, state governments, and non-profits. The project's objectives include conducting microbiological tests, integrating with FDA surveillance efforts, and sharing data with public health agencies. Successful applicants will receive substantial involvement from FDA staff throughout the project period, which can extend up to five years, contingent upon performance and funding availability. Overall, this initiative underscores a concerted effort to address public health threats posed by antibiotic resistance in food sources.